Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
55
RIGL Quote, Financials, Valuation and Earnings
Last price:
$37.52
Seasonality move
:
-7.55%
Day range:
$37.20 - $38.49
52-week range:
$15.50 - $52.24
Dividend yield:
0%
P/E ratio:
6.08x
P/S ratio:
2.44x
P/B ratio:
5.78x
Volume:
275.8K
Avg. volume:
553.5K
1-year change:
116.02%
Market cap:
$680.3M
Revenue:
$179.3M
EPS (TTM):
$6.17
Earnings Data
Next earnings date for RIGL
Mar 03
2026
Most recent earnings per share
$1.46
Beat by $0.52
(Nov 4/2025)
Consensus Estimate
$0.94
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RIGL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $59.3M | -- | -- | -- | -- |
| 03/03/2026 | Q4 | $68M | -- | -- | $1.19 | -- |
| 11/04/2025 | Q3 | $61.9M | $69.5M | $1.46 | $0.94 | $0.52 |
| 08/05/2025 | Q2 | $72.6M | $101.7M | $3.28 | $1.41 | $1.88 |
| 05/06/2025 | Q1 | $43.9M | $53.3M | $0.63 | $0.09 | $0.54 |
| 03/04/2025 | Q4 | $57.6M | $57.6M | $0.80 | $0.58 | $0.22 |
| 11/07/2024 | Q3 | $41.9M | $55.3M | $0.70 | $0.06 | $0.64 |
| 08/06/2024 | Q2 | $33.7M | $36.8M | -$0.06 | -$0.18 | $0.12 |
| 05/07/2024 | Q1 | $31.5M | $29.5M | -$0.47 | -$0.27 | -$0.21 |
| 03/05/2024 | Q4 | $33.4M | $35.8M | $0.04 | -$0.24 | $0.28 |
| 11/07/2023 | Q3 | -- | $28.1M | -$0.33 | -- | -- |
| 08/01/2023 | Q2 | -- | $26.9M | -$0.38 | -- | -- |
| 05/02/2023 | Q1 | -- | $26.1M | -$0.78 | -- | -- |
| 03/07/2023 | Q4 | -- | $51.3M | $0.08 | -- | -- |
| 11/03/2022 | Q3 | -- | $22.4M | -$1.10 | -- | -- |
| 08/02/2022 | Q2 | -- | $29.8M | -$0.78 | -- | -- |
| 05/03/2022 | Q1 | -- | $16.7M | -$1.60 | -- | -- |
| 03/01/2022 | Q4 | -- | $20.4M | -$1.32 | -- | -- |
| 11/02/2021 | Q3 | -- | $21.5M | -$1.23 | -- | -- |
| 08/03/2021 | Q2 | -- | $26.3M | -$0.81 | -- | -- |
| 05/05/2021 | Q1 | -- | $81M | $2.24 | -- | -- |
| 03/02/2021 | Q4 | -- | $18.5M | -$1.14 | -- | -- |
| 11/05/2020 | Q3 | -- | $18.4M | -$0.84 | -- | -- |
| 08/04/2020 | Q2 | -- | $16M | -$1.04 | -- | -- |
| 05/05/2020 | Q1 | -- | $55.8M | $1.26 | -- | -- |
| 02/27/2020 | Q4 | -- | $15.4M | -$1.03 | -- | -- |
| 11/05/2019 | Q3 | -- | $20.9M | -$0.69 | -- | -- |
| 08/06/2019 | Q2 | -- | $10.4M | -$1.23 | -- | -- |
| 05/07/2019 | Q1 | -- | $12.6M | -$1.05 | -- | -- |
| 02/28/2019 | Q4 | -- | $37.9M | $0.19 | -- | -- |
| 11/06/2018 | Q3 | -- | $4.9M | -$1.43 | -- | -- |
| 08/08/2018 | Q2 | -- | $1.8M | -$1.60 | -- | -- |
| 05/01/2018 | Q1 | -- | -- | -$1.70 | -- | -- |
| 03/06/2018 | Q4 | -- | -- | -$1.80 | -- | -- |
| 11/01/2017 | Q3 | -- | $900K | -$1.40 | -- | -- |
| 08/01/2017 | Q2 | -- | -- | -$1.60 | -- | -- |
| 04/25/2017 | Q1 | -- | $3.6M | -$1.30 | -- | -- |
| 03/07/2017 | Q4 | -- | $3M | -$1.60 | -- | -- |
| 11/01/2016 | Q3 | -- | $3.8M | -$2.40 | -- | -- |
| 08/02/2016 | Q2 | -- | $8.6M | -$1.50 | -- | -- |
| 05/03/2016 | Q1 | -- | $5M | -$1.90 | -- | -- |
Rigel Pharmaceuticals, Inc. Earnings Questions
-
How Much did Rigel Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Rigel Pharmaceuticals, Inc. reported $69.5M worth of top line sales in its most recent quarter.
-
Did Rigel Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Rigel Pharmaceuticals, Inc. announced earnings per share of $1.46 which represents a beat of analyst forecast a $0.94 per share.
-
Is Rigel Pharmaceuticals, Inc. Profitable?
Rigel Pharmaceuticals, Inc. reported $64.7M that represents $3.38 per share over the last quarter.
-
What is the Analyst Consensus for Rigel Pharmaceuticals, Inc. EPS Next Year?
Rigel Pharmaceuticals, Inc.'s earnings are forecast to grow from $0.99 per share to $6.76 per share next year representing an increase of 574.06%.
-
When is Rigel Pharmaceuticals, Inc.'s Earnings Date?
Rigel Pharmaceuticals, Inc.'s next earnings date is March 3, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
